Ibogaine in the News
Ibogaine in the news

Ibogaine is dominating recent news headlines through major federal pushes, clinical milestones, and research initiatives:
-
- FDA Public Comment & Trial Design: The U.S. Food and Drug Administration issued a Request for Information (RFI) to gather public input and data on early-phase clinical trial designs for ibogaine drug products, with the comment window open through November 20, 2026 (
Docket No. FDA-2026-N-10429). You can review the announcement on the FDA Press Announcements Page. [1]
- FDA Public Comment & Trial Design: The U.S. Food and Drug Administration issued a Request for Information (RFI) to gather public input and data on early-phase clinical trial designs for ibogaine drug products, with the comment window open through November 20, 2026 (
- White House & Interagency Push: Driven by an executive order to accelerate medical treatments for serious mental illness and veteran suicide crises, the administration, HHS, the VA, and the FDA are coordinating on fast-tracked research, federal funding, and real-world evidence pathways for psychedelics like ibogaine. [1, 2]
- Stanford Veteran Study Results: Stanford Medicine published a 12-month observational trial in Translational Psychiatry examining special forces veterans treated with oral ibogaine in Mexico for traumatic brain injury (TBI), PTSD, depression, and anxiety, reporting sustained long-term remission rates. Read the summary via Stanford Medicine News. [1]
- Domestic U.S. Trials: Barrow Neurological Institute and Arizona State University (ASU) announced a $5 million state-funded clinical trial evaluating ibogaine safety and efficacy for PTSD, depression, and addiction, with participant enrollment slated to begin in 2027. [1]
Would you like to explore:
The specific medical or cardiac risks associated with ibogaine?Details on the federal executive order or funding programs?Current legal status and state-level policy efforts?
-
U.S. Food and Drug Administration (.gov)FDA Seeks Public Input to Support Ibogaine Research | FDAOctober 5, 2026 — Action: FDA issued a Request for Information (RFI) seeking public input, comments, and data on early-phase clinical trial designs …
-
Stanford MedicineOne year after taking ibogaine, veterans find continued relief from PTSDOctober 6, 2026 — Study: Stanford Medicine observational trial published in Translational Psychiatry (Aug 12). Participants: 30 special forces veter…
-
ASU NewsBarrow, ASU embark on one of first clinical trials of ibogaine in the US | ASU NewsAugust 31, 2026 — Partnership: Barrow Neurological Institute and Arizona State University (ASU); $5 million grant from Arizona Department of Health …
Show all
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more



